6 new stocks added last week by ProPicks AI are already up by 2.5%. Don't miss the momentum!Get 50% off

New COVID-19 cases rise in France amid fears of new lockdown

Published 01/26/2021, 02:30 PM
Updated 01/26/2021, 02:35 PM
© Reuters. People, wearing protective face masks, walk in Nantes
PFE
-
SNY
-

PARIS (Reuters) - The daily number of new COVID-19 cases in France stayed above 20,000 on average for the fourth straight day on Tuesday while hospitalisations kept growing to reach an eight-week high of 27,041, increasing fears of a third national lockdown.

President Emmanuel Macron still hopes a 6 p.m. curfew put in place 11 days ago will be enough to rein in the surge in new infections prompted by the emergence of more contagious variants of the coronavirus.

Despite calls from some doctors and medics for a new lockdown, government minister Agnes Pannier-Runacher said earlier there was no need to make a decision on such a measure at this stage.

Macron will head the weekly cabinet meeting on Wednesday and a government COVID-19 press conference is scheduled for Thursday.

Health authorities reported 22,086 new coronavirus infections over the previous 24 hours on Tuesday, up sharply from Monday's 4,240, giving a seven-day moving average, which averages out daily data-reporting irregularities, of 20,230.

The government needs that figure to go below 5,000 to regard the pandemic as being fully under control.

The number of people being treated in intensive-care units (ICUs) for COVID-19 was also up, at 3,081, staying above the key 3,000 threshold for the second day running. A drop below 3,000 led the government to relax the second lockdown on Dec. 15.

France's cumulative total of infections now stands at 3,079,943, the sixth highest in the world.

Its COVID-19 death toll rose by 612 to 74,106, the world's seventh highest, after an increase of 445 on Monday. The seven-day moving average of new fatalities stands at 395.

© Reuters. People, wearing protective face masks, walk in Nantes

After France's Pasteur Institute said on Monday it had decided to halt one its potential COVID-19 vaccine projects, French pharmaceutical giant Sanofi (NASDAQ:SNY) said it would aim to supply more than 100 million doses of Pfizer (NYSE:PFE)'s COVID-19 vaccine from July.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.